Cancer research

Abstract LB516A: The irreversible FLT3 inhibitor FF-10101 is active against a diversity of FLT3 inhibitor resistance mechanisms.

Cancer research

Timothy T. Ferng, Daisuke Terada, Makoto Ando, Theodore C. Tarver, Fihr Chaudhary, Kimberly C. Lin, Aaron C. Logan, Catherine C. Smith

MET Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma.

Cancer research

Lu X, Peled N, Greer J, Wu W, Choi P, Berger AH, Wong S, Jen KY, Seo Y, Hann B, Brooks A, Meyerson M, Collisson EA

Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression.

Cancer research

Trejo CL, Green S, Marsh V, Collisson EA, Iezza G, Phillips WA, McMahon M

Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade.

Cancer research

Collisson EA, De A, Suzuki H, Gambhir SS, Kolodney MS